Overview of Dr. Sugarman

Dr. Steven Sugarman is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan-Kettering Cancer Center and St. Catherine of Siena Medical Center. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 31 years. Dr. Sugarman accepts several types of health insurance, listed below. He is one of 468 doctors at Memorial Sloan-Kettering Cancer Center and one of 87 doctors at St. Catherine of Siena Medical Center who specialize in Oncology. He has more than 30 publications and over 500 citings.

Education & Training

• University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1989 - 1992

• Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1986 - 1989

• State University of New York Downstate Medical Center College of MedicineClass of 1986

Certifications & Licensure

• NY State Medical License 1988 - 2024

• NJ State Medical License 2019 - 2021

• TX State Medical License 1989 - 1994

• American Board of Internal Medicine Internal Medicine
• American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

• 15 citations

  Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).

  Shirley M. Bluethmann, Catherine M. Alfano, Jonathan D. Clapp, George Luta, Brent J. Small, Arti Hurria, Harvey J. Cohen, Steven Sugarman, Hyman B. Muss, Claudine Isaa...> ;Breast Cancer Research and Treatment. 2017 Jun 26
• 20 citations

  Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2‐Positive Ea...

  Jasmeet Chadha Singh, Anita Mamtani, Andrea V. Barrio, Monica Morrow, Steven Sugarman, Lee W. Jones, Anthony F. Yu, Daniel F. Argolo, L.M. Smyth, Shanu Modi, Sarah J. ...> ;The Oncologist. 2017 Feb 1
• 27 citations

  Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival...

  L.M. Smyth, Neil M. Iyengar, Melanie Chen, S. M. Popper, S. Patil, Carolyn Wasserheit-Lieblich, Daniel F. Argolo, Jasmeet Chadha Singh, Sarat Chandarlapaty, Steven Sug...> ;Breast Cancer Research and Treatment. 2016 Jun 15
• Join now to see all

Press Mentions

• Clinical Trials Saving Breast Cancer Patient Lives: A Long Island New York StoryOctober 28th, 2020

• Breast Cancer Clinical Trials at Long Island Hospitals Offering New HopeOctober 27th, 2020

Hospital Affiliations

Insurance Accepted

• Aetna Choice POS II
  Aetna HMO
  BCBS Blue Card PPO
  CIGNA HMO
  CIGNA Open Access
  CIGNA PPO
  Empire BCBS HMO
  Empire BCBS PPO
  GHI PPO
  Great West PPO
  

  Humana ChoiceCare Network PPO
  Multiplan PHCS PPO
  Multiplan PPO
  MVP Healthcare PPO
  Oxford Health Freedom
  Oxford Health Liberty
  QualCare HMO
  QualCare PPO
  United Healthcare - Direct Choice Plus POS
  United Healthcare - Direct Options PPO
  

• Please verify your coverage with the provider's office directly when scheduling an appointment